
AstraZeneca PLC
AZN 174.35 (-0.60%) 1.05
EV: $339.72(B)
Total Equity: $51.81(B)
Debt/Equity: 0.66
Dividend/share: $3.2
Div. yield: 1.85%
P/E: 24.49
Forward P/E: 17.09
P/FCF: 26.50
P/S: 4.33
P/B: 5.23
EPS: $7.1
EPS (fwd): $10.2
FCF/share: $6.6
Revenue/share: $40.3
Book value/share: $33.4
ROIC: 12.5%
ROA: 8.6%
ROE: 21.7%
Margins: Gross | Op. | Net
81.8% | 22.0% | 17.7%
0.0%of Portfolio
My holdings
Day change
Total change
ROIC > 10% Debt/Equity < 1 Net Margin > 10% Past Net Income CAGR > 0% Est. EPS Growth > 5%
5Y Shares Out Change < 0% Current Ratio > 1 Quick Ratio > 1
TTM Financials
Income (TTM)
Revenue$62.38(B)
Gross profit$51.02(B)
EBITDA$21.28(B)
Net income$11.03(B)
Gross margin81.8%
Operating margin22.0%
Net margin17.7%
Shares outstanding1.55(B)
Balance sheet
Total assets$119.92(B)
Current assets$31.45(B)
Total liabilities$68.11(B)
Current liabilities$31.27(B)
Cash & Short-term inv.$8.17(B)
Long-term debt$26.57(B)
Total intangibles$59.30(B)
PP&E$16.78(B)
Cash flow (TTM)
FCF$10.21(B)
CapEx$-3.02(B)
Dividends paid$-4.83(B)
Stock issued$43.00(M)
Stock repurchased$-776.00(M)
Stock-based comp.$719.00(M)
Debt issued$5.41(B)
Debt repaid$-4.85(B)
